Literature DB >> 30085111

Malignant and Nonmalignant Complications of the Rectal Stump in Patients with Inflammatory Bowel Disease.

Joren R Ten Hove1, Jonathan M K Bogaerts1, Michiel T J Bak1, Miangela M Laclé2, Vincent Meij3, Lauranne A A P Derikx4, Frank Hoentjen4, Nofel Mahmmod5, Sebastiaan A van Tuyl6, Bas Oldenburg1.   

Abstract

Background: Patients with refractory inflammatory bowel disease (IBD) might require a subtotal colectomy with construction of an ileostomy. Due to the risk of nerve damage and pelvic sepsis, the diverted rectum is often left in situ. Evidence on long-term complications of this rectal stump is limited, particularly in patients with Crohn's disease (CD). In addition to the risk of development of neoplasia, diversion proctitis is a frequently reported rectal stump associated complication. Surprisingly, clear recommendations concerning rectal stump surveillance and timing of proctectomy are lacking.
Methods: Through the use of a pathology database and a review of medical records, we established a cohort of IBD patients with a diverted rectum. Among these patients, long-term complications of the rectal stump were identified. Main endpoint was advanced neoplasia (carcinoma or high-grade dysplasia [HGD]) in the rectal stump. Risk factors for advanced neoplasia were identified using Cox regression modeling. In the second, prospective part of the study, a questionnaire was sent out to 165 patients with either a rectal stump in situ or who had undergone a proctectomy, in order to identify differences in patient-reported outcome measures associated with the excision of the rectal stump.
Results: From 530 patients with IBD and a (temporal) diversion of the rectum, we included 250 patients in whom the rectal stump was left in situ for more than 12 months. The majority of patients was female (61%) and had Crohn's disease (67%). On follow-up (median 8 years), 8 carcinomas, 2 cases of high-grade dysplasia, and 7 cases of low-grade dysplasia were found with incidence rates of 3.9 and 8.5 per 1000 patient-years of follow-up for cancer and all neoplasia, respectively. The 8 cases of rectal stump cancer (RSC) were diagnosed after a median of 15 years after colectomy. A history of colorectal neoplasia was associated with advanced rectal stump neoplasia. Out of 191 patients with endoscopic follow-up, rectal stump inflammation occurred in 161 (88.5%) patients. Results of the questionnaire did not show a significant difference in quality of life between patients with and patients without a rectal stump, although the latter group reported significantly more sexual and urinary symptoms than patients with a rectal stump in situ. The majority of rectal stump patients reported rectal blood loss, but 65.5% of them were not or barely limited in daily life by their rectal stumprelated problems.
Conclusion: Rectal stump cancer has a low incidence rate, with patients with a history of colonic neoplasia carrying the highest risk of developing this severe complication. We observed no significant differences in quality of life between rectal stump and postproctectomy patients, but proctectomy surgery is associated with sexual and urinary complications.

Entities:  

Mesh:

Year:  2019        PMID: 30085111     DOI: 10.1093/ibd/izy253

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  7 in total

Review 1.  Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): Crohn's disease.

Authors:  G Pellino; D S Keller; G M Sampietro; I Angriman; M Carvello; V Celentano; F Colombo; F Di Candido; S Laureti; G Luglio; G Poggioli; M Rottoli; S Scaringi; G Sciaudone; G Sica; L Sofo; S Leone; S Danese; A Spinelli; G Delaini; F Selvaggi
Journal:  Tech Coloproctol       Date:  2020-03-14       Impact factor: 3.781

2.  A contemporary series of surgical outcomes following subtotal colectomy and/or completion proctectomy for management of inflammatory bowel disease.

Authors:  Lucy Burns; Michael E Kelly; Maria Whelan; James O'Riordan; Paul Neary; Dara O Kavanagh
Journal:  Ir J Med Sci       Date:  2022-01-17       Impact factor: 1.568

3.  Inflammation of the rectal remnant endangers the outcome of ileal pouch-anal anastomosis: a case-control study.

Authors:  Jan P Frese; Jörn Gröne; Johannes C Lauscher; Martin E Kreis; Benjamin Weixler; Katharina Beyer; Claudia Seifarth
Journal:  Int J Colorectal Dis       Date:  2022-06-17       Impact factor: 2.796

4.  Transperineal total mesorectal excision for rectal cancer on the residual rectum after multiple abdominal surgeries in a patient with Crohn's disease: a case report.

Authors:  Shin Emoto; Shigenori Homma; Tadashi Yoshida; Nobuki Ichikawa; Yoichi Miyaoka; Hiroki Matsui; Ryo Takahashi; Keita Ishido; Takuya Otsuka; Tomoko Mitsuhashi; Takehiko Katsurada; Akinobu Taketomi
Journal:  Surg Case Rep       Date:  2021-05-13

5.  Subtotal colectomy in ulcerative colitis-long term considerations for the rectal stump.

Authors:  Orla Hennessy; Laurence Egan; Myles Joyce
Journal:  World J Gastrointest Surg       Date:  2021-02-27

6.  Diversion proctocolitis and the problem of the forgotten rectum in inflammatory bowel diseases: A systematic review.

Authors:  Arianna Dal Buono; Michele Carvello; David B Sachar; Antonino Spinelli; Silvio Danese; Giulia Roda
Journal:  United European Gastroenterol J       Date:  2021-11-29       Impact factor: 4.623

7.  Correlation of Serum CA242, CA724, and TPA Levels with Clinicopathological Features and Prognosis in Patients with Inflammatory Bowel Disease Complicated with Rectal Cancer.

Authors:  Hongliang Liang; Xi Yang
Journal:  J Oncol       Date:  2022-09-19       Impact factor: 4.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.